BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 15756432)

  • 1. Expression of cell adhesion molecules and chemokine receptors: angioinvasiveness in nasal NK/T-cell lymphoma.
    Liu A; Nakatsuka S; Yang WI; Kojya S; Aozasa K
    Oncol Rep; 2005 Apr; 13(4):613-20. PubMed ID: 15756432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytotoxic granular protein expression, Epstein-Barr virus strain type, and latent membrane protein-1 oncogene deletions in nasal T-lymphocyte/natural killer cell lymphomas from Mexico.
    Elenitoba-Johnson KS; Zarate-Osorno A; Meneses A; Krenacs L; Kingma DW; Raffeld M; Jaffe ES
    Mod Pathol; 1998 Aug; 11(8):754-61. PubMed ID: 9720504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr virus BART9 miRNA modulates LMP1 levels and affects growth rate of nasal NK T cell lymphomas.
    Ramakrishnan R; Donahue H; Garcia D; Tan J; Shimizu N; Rice AP; Ling PD
    PLoS One; 2011; 6(11):e27271. PubMed ID: 22102884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nasal NK- and T-cell lymphomas share the same type of Epstein-Barr virus latency as nasopharyngeal carcinoma and Hodgkin's disease.
    Chiang AK; Tao Q; Srivastava G; Ho FC
    Int J Cancer; 1996 Nov; 68(3):285-90. PubMed ID: 8903467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-Barr virus in non-Hodgkin's lymphomas of the upper respiratory tract: association with sinonasal localization and expression of NK and/or T-cell antigens by tumour cells.
    Kanavaros P; Briere J; Lescs MC; Gaulard P
    J Pathol; 1996 Mar; 178(3):297-302. PubMed ID: 8778335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Expression of Epstein-Barr virus genes in EBV-associated gastric carcinoma].
    Wang Y; Luo B; Zhao P; Huang BH
    Ai Zheng; 2004 Jul; 23(7):782-7. PubMed ID: 15248912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene mutation analysis of sinonasal lymphomas in Indonesia.
    Kurniawan AN; Hongyo T; Hardjolukito ES; Ham MF; Takakuwa T; Kodariah R; Hoshida Y; Nomura T; Aozasa K
    Oncol Rep; 2006 May; 15(5):1257-63. PubMed ID: 16596195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High frequency of EBV association and 30-bp deletion in the LMP-1 gene in CD56 lymphomas of the upper aerodigestive tract.
    Tai YC; Kim LH; Peh SC
    Pathol Int; 2004 Mar; 54(3):158-66. PubMed ID: 14989738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Features of intestinal T-cell lymphomas in Chinese population without evidence of celiac disease and their close association with Epstein-Barr virus infection.
    Zhang WY; Li GD; Liu WP; Ouyang Q; Ren XC; Li FY; Xu H
    Chin Med J (Engl); 2005 Sep; 118(18):1542-8. PubMed ID: 16232331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical usefulness of serum EBV DNA levels of BamHI W and LMP1 for Nasal NK/T-cell lymphoma.
    Ishii H; Ogino T; Berger C; Köchli-Schmitz N; Nagato T; Takahara M; Nadal D; Harabuchi Y
    J Med Virol; 2007 May; 79(5):562-72. PubMed ID: 17385697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The latency pattern of Epstein-Barr virus infection and viral IL-10 expression in cutaneous natural killer/T-cell lymphomas.
    Xu ZG; Iwatsuki K; Oyama N; Ohtsuka M; Satoh M; Kikuchi S; Akiba H; Kaneko F
    Br J Cancer; 2001 Apr; 84(7):920-5. PubMed ID: 11286472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of interleukin-9 in nasal natural killer/T-cell lymphoma cell lines and patients.
    Nagato T; Kobayashi H; Kishibe K; Takahara M; Ogino T; Ishii H; Oikawa K; Aoki N; Sato K; Kimura S; Shimizu N; Tateno M; Harabuchi Y
    Clin Cancer Res; 2005 Dec; 11(23):8250-7. PubMed ID: 16322282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr virus (EBV) latent membrane protein-1-specific cytotoxic T lymphocytes targeting EBV-carrying natural killer cell malignancies.
    Demachi-Okamura A; Ito Y; Akatsuka Y; Tsujimura K; Morishima Y; Takahashi T; Kuzushima K
    Eur J Immunol; 2006 Mar; 36(3):593-602. PubMed ID: 16479544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of immunophenotype of sinonasal non-Hodgkin's lymphoma to Epstein-Barr virus infection.
    Feng YF; Wu QL; Zong YS
    Ai Zheng; 2007 Nov; 26(11):1170-6. PubMed ID: 17991313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of Epstein-Barr virus-infected mucosal lymphocytes in nasal polyps.
    Tao Q; Srivastava G; Dickens P; Ho FC
    Am J Pathol; 1996 Oct; 149(4):1111-8. PubMed ID: 8863660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations in ATR in nasal NK/T-cell lymphoma and chronic active Epstein-Barr virus infection.
    Liu A; Takakuwa T; Luo WJ; Fujita S; Aozasa K
    Cancer Sci; 2006 Jul; 97(7):605-10. PubMed ID: 16827800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intestinal T-cell and natural killer-cell lymphomas in Taiwan with special emphasis on 2 distinct cellular types: natural killer-like cytotoxic T cell and true natural killer cell.
    Tung CL; Hsieh PP; Chang JH; Chen RS; Chen YJ; Wang JS
    Hum Pathol; 2008 Jul; 39(7):1018-25. PubMed ID: 18482744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr virus (EBV)-encoded RNA promotes growth of EBV-infected T cells through interleukin-9 induction.
    Yang L; Aozasa K; Oshimi K; Takada K
    Cancer Res; 2004 Aug; 64(15):5332-7. PubMed ID: 15289339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokine mediated induction of the major Epstein-Barr virus (EBV)-encoded transforming protein, LMP-1.
    Kis LL; Takahara M; Nagy N; Klein G; Klein E
    Immunol Lett; 2006 Apr; 104(1-2):83-8. PubMed ID: 16386314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequency of a 30-base pair deletion in the latent membrane protein-1 gene in Epstein-Barr virus-associated lymphomas in Japan.
    Hirose Y; Masaki Y; Kurose N
    Int J Hematol; 2000 Aug; 72(2):210-5. PubMed ID: 11039671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.